Novel interpretation of molecular diagnosis of congenital toxoplasmosis according to gestational age at the time of maternal infection

Journal of Clinical Microbiology

Volumn 50, Issue 12, 2012, Pages 3944-3951

  Sterkers, Yvon ^a   Pratlong, Francine ^a   Albaba, Sahar ^a   Loubersac, Julie ^a   Picot, Marie Christine ^a,b   Pretet, Vanessa ^a   Issert, Eric ^a   Boulot, Pierre ^a   Bastien, Patrick ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMENORRHEA; AMNIOCENTESIS; AMNION FLUID; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FEMALE; GESTATIONAL AGE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MEDICAL DECISION MAKING; MOLECULAR DIAGNOSIS; PARASITE IDENTIFICATION; PATIENT GUIDANCE; PLACENTA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SERODIAGNOSIS; TOXOPLASMA; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; AMNIOTIC FLUID; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOXOPLASMOSIS, CONGENITAL; UNITED STATES; YOUNG ADULT;

EID: 84869220108     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00918-12     Document Type: Article

References (42)

1. Ajzenberg D, et al. 2002. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J. Infect. Dis. 186:684-689. (Pubitemid 34925541)
2. Anonymous. 1992. Congenital toxoplasmosis, Copenhagen, January 17, 1992. Proceedings. Scand. J. Infect. Dis. Suppl. 84:1-96.
3. Bastien P. 2002. Molecular diagnosis of toxoplasmosis. Trans. R. Soc. Trop. Med. Hyg. 96(Suppl 1):S205-S215.
4. Berger F, Goulet G, Le Strat Y, Desenclos J. 2008. Toxoplasmosis in pregnant women in France: trends in seroprevalence and incidence, and associated factors, 1995-2003. Bull. Epidémiol. Hebdomadaire 14-15:117-121. (In French.)
5. Bessieres MH, et al. 2009. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem. Inst. Oswaldo Cruz 104:389-392.
6. Bessieres MH, et al. 2001. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur. J. Obstet. Gynecol. Reprod. Biol. 94:37-45. (Pubitemid 32007997)
7. Boyer K, et al. 2011. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin. Infect. Dis. 53:1081-1089.
8. Bretagne S, et al. 1993. Detection of Toxoplasma gondii by competitive DNA amplification of bronchoalveolar lavage samples. J. Infect. Dis. 168:1585-1588. (Pubitemid 23344931)
9. Burg JL, Grover CM, Pouletty P, Boothroyd JC. 1989. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 27:1787-1792. (Pubitemid 19182881)
10. Cassaing S, et al. 2006. Comparison between two amplification sets for molecular diagnosis of toxoplasmosis by real-time PCR. J. Clin. Microbiol. 44:720-724.
11. Chabbert E, Lachaud L, Crobu L, Bastien P. 2004. Comparison of two widely used PCR primer systems for detection of Toxoplasma in amniotic fluid, blood, and tissues. J. Clin. Microbiol. 42:1719-1722. (Pubitemid 38500822)
12. Costa JM, Ernault P, Gautier E, Bretagne S. 2001. Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes. Prenat. Diagn. 21:85-88.
13. Desmonts G. 1971. Congenital toxoplasmosis: problems in early diagnosis, p 137-149. In Hentsch D (ed), Toxoplasmosis. Hans Huber Publishers, Bern, Switzerland.
14. Desmonts G, Couvreur J. 1974. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull. N. Y. Acad. Med. 50:146-159.
15. Dunn D, et al. 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829-1833. (Pubitemid 29251014)
16. Filisetti D, Cocquerelle V, Pfaff A, Villard O, Candolfi E. 2010. Placental testing for Toxoplasma gondii is not useful to diagnose congenital toxoplasmosis. Pediatr. Infect. Dis. J. 29:665-667.
17. Fricker-Hidalgo H, et al. 2007. Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 26:845-846. (Pubitemid 47329860)
18. Fricker-Hidalgo H, et al. 1998. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo, and in vitro cultures. Placenta 19:545-549. (Pubitemid 28430009)
19. Guy E, et al. 1996. Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluid. Eur. J. Clin. Microbiol. Infect. Dis. 15:836-839. (Pubitemid 26386132)
20. Hohlfeld P, et al. 1994. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N. Engl. J. Med. 331:695-699.
21. Jenum PA, Holberg-Petersen M, Melby KK, Stray-Pedersen B. 1998. Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. The Norwegian experience. APMIS 106:680-686. (Pubitemid 28383442)
22. King L, et al. 2008. Congenital toxoplasmosis: implementation of a surveillance system in France. Bull. Epidémiol. Hebdomadaire 14-15:122-123. (In French.)
23. Lebech M, et al. 1996. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 15:799-805. (Pubitemid 26386122)
24. Naessens A, et al. 1999. Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J. Pediatr. 135:714-719. (Pubitemid 30180420)
25. Pratlong F, et al. 1994. Fetal diagnosis of toxoplasmosis in 190 women infected during pregnancy. Prenat. Diagn. 14:191-198. (Pubitemid 24101557)
26. Pratlong F, et al. 1996. Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients. Br. J. Obstet. Gynaecol. 103:552-557. (Pubitemid 26001003)
27. Remington J, McLeod R, Wilson C, Desmonts G. 2010. Toxoplasmosis, p 918-1041. In Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado Y (ed), Infectious diseases of the fetus and newborn infant, 7th ed. Saunders-Elsevier, Philadelphia, PA.
28. Remington JS, Thulliez P, Montoya JG. 2004. Recent developments for diagnosis of toxoplasmosis. J. Clin. Microbiol. 42:941-945. (Pubitemid 38332808)
29. Robert-Gangneux F, et al. 2010. Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 29:33-38.
30. Robert-Gangneux F, et al. 1999. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J. Clin. Microbiol. 37:2893-2898. (Pubitemid 29391906)
31. Robert-Gangneux F, et al. 2011. The placenta: a main role in congenital toxoplasmosis? Trends Parasitol. 27:530-536.
32. Romand S, et al. 2004. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am. J. Obstet. Gynecol. 190:797-802. (Pubitemid 38406796)
33. Romand S, et al. 2001. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet. Gynecol. 97:296-300. (Pubitemid 32126349)
34. Simel DL, Samsa GP, Matchar DB. 1991. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J. Clin. Epidemiol. 44:763-770.
35. Sterkers Y, et al. 2010. Multicentric comparative analytical performance study for molecular detection of low amounts of Toxoplasma gondii from simulated specimens. J. Clin. Microbiol. 48:3216-3222.
36. Sterkers Y, Varlet-Marie E, Marty P, Bastien P. 2010. Diversity and evolution of methods and practices for the molecular diagnosis of congenital toxoplasmosis in France: a 4-year survey. Clin. Microbiol. Infect. 16:1594-1602.
37. Thalib L, et al. 2005. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. Br. J. Obstet. Gynaecol. 112:567-574. (Pubitemid 40675790)
38. Thulliez P. 1992. Screening programme for congenital toxoplasmosis in France. Scand. J. Infect. Dis. Suppl. 84:43-45. (Pubitemid 23048972)
39. Vidigal PV, et al. 2002. Prenatal toxoplasmosis diagnosis from amniotic fluid by PCR. Rev. Soc. Bras. Med. Trop. 35:1-6.
40. Villena I, et al. 2010. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 15:19600. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19600.
41. Wallon M, et al. 1999. Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur. J. Pediatr. 158:645-649. (Pubitemid 29331033)
42. Wallon M, et al. 2010. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet. Gynecol. 115:727-733.